Your browser doesn't support javascript.
loading
Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn's disease: report of the OPERA study.
Sandborn, William J; Lee, Scott D; Tarabar, Dino; Louis, Edouard; Klopocka, Maria; Klaus, Jochen; Reinisch, Walter; Hébuterne, Xavier; Park, Dong-Il; Schreiber, Stefan; Nayak, Satyaprakash; Ahmad, Alaa; Banerjee, Anindita; Brown, Lisa S; Cataldi, Fabio; Gorelick, Kenneth J; Cheng, John B; Hassan-Zahraee, Mina; Clare, Robert; D'Haens, Geert R.
Afiliación
  • Sandborn WJ; Department of Medicine, Division of Gastroenterology, University of California San Diego, La Jolla, California, USA.
  • Lee SD; Department of Medicine, Division of Gastroenterology, University of Washington, Seattle, Washington, USA.
  • Tarabar D; Clinic of Gastroenterology and Hepatology, Military Medical Academy, Belgrade, Serbia.
  • Louis E; Department of Gastroenterology, University Hospital CHU of Liege, Liège, Belgium.
  • Klopocka M; Department of Vascular Diseases and Internal Medicine, Nicolaus Copernicus University, Torun, Collegium Medicum in Bydgoszcz, Poland.
  • Klaus J; Department of Medicine, Universitatsklinikum Ulm, Ulm, Germany.
  • Reinisch W; Department of Medicine, Division of Gastroenterology, Medical University of Vienna, Vienna, Austria.
  • Hébuterne X; Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, Canada.
  • Park DI; Department of Medicine, Université de Nice Sophia Antipolis, Hôpital de l'Archet, Nice, France.
  • Schreiber S; Department of Internal Medicine, Division of Gastroenterology, Kangbuk Samsung Hospital, Sungkyunkwan University, Seoul, South Korea.
  • Nayak S; Department of Medicine, University of Kiel, Kiel, Germany.
  • Ahmad A; Department of Gastroenterology, Pfizer, Cambridge, Massachusetts, USA.
  • Banerjee A; Department of Gastroenterology, Pfizer, Cambridge, Massachusetts, USA.
  • Brown LS; Department of Gastroenterology, Pfizer, Cambridge, Massachusetts, USA.
  • Cataldi F; Department of Gastroenterology, Pfizer, Cambridge, Massachusetts, USA.
  • Gorelick KJ; Department of Gastroenterology, Pfizer, Cambridge, Massachusetts, USA.
  • Cheng JB; Department of Gastroenterology, Pfizer, Cambridge, Massachusetts, USA.
  • Hassan-Zahraee M; Department of Gastroenterology, Pfizer, Cambridge, Massachusetts, USA.
  • Clare R; Department of Gastroenterology, Pfizer, Cambridge, Massachusetts, USA.
  • D'Haens GR; Department of Gastroenterology, Pfizer, Cambridge, Massachusetts, USA.
Gut ; 67(10): 1824-1835, 2018 10.
Article en En | MEDLINE | ID: mdl-28982740
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Gut Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Gut Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos